Work

Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC

Year: 2009

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-08-1930

Authors: Pamela Munster, Douglas Marchion, Elona Bicaku, Mira Lacevic, Jongphil Kim, Barbara Centeno, Adil Daud, Anthony Neuger, Susan Minton, Daniel Sullivan

Institutions: University of California, San Francisco, Moffitt Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Potentiation of Topo Inhibitors by the HDACi, SAHA, Potentiation of Topo Inhibitors by HDAC Inhibitors

OpenAlex ID: W2136103407

FWCI: 7.24

Cites: 50

Cited by: 150

Related to: 10